Mesoblast Limited (ASX:MSB)
1.650
+0.030 (1.85%)
Apr 17, 2025, 4:10 PM AEST
Mesoblast Employees
Mesoblast had 73 employees as of June 30, 2024. The number of employees decreased by 10 or -12.05% compared to the previous year.
Employees
73
Change (1Y)
-10
Growth (1Y)
-12.05%
Revenue / Employee
125.51K AUD
Profits / Employee
-2.29M AUD
Market Cap
2.10B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CSL Limited | 32,698 |
Cochlear | 5,097 |
Sonic Healthcare | 42,000 |
Telix Pharmaceuticals | 234 |
Ramsay Health Care | 90,000 |
Ansell | 15,000 |
Regis Healthcare | 11,000 |
Nanosonics | 466 |
Mesoblast News
- 1 day ago - Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives - GlobeNewsWire
- 15 days ago - Mesoblast Allogeneic Cell Therapy Products Are Designated 'U.S. Country of Origin' and Not Subject to U.S. Tariffs - Benzinga
- 15 days ago - Mesoblast Allogeneic Cell Therapy Products Are Designated ‘U.S. Country of Origin' and Not Subject to U.S. Tariffs - GlobeNewsWire
- 16 days ago - Mesoblast Files Request for Type B Meeting with FDA to Discuss Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure - GlobeNewsWire
- 19 days ago - First Three Children to Commence Treatment With Ryoncil® - GlobeNewsWire
- 22 days ago - Mesoblast Ltd (MESO) Announces FDA Approval and U.S. ... - GuruFocus
- 23 days ago - Ryoncil® is Now Available for Purchase in the United States - GlobeNewsWire
- 5 weeks ago - Ryoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United States - GlobeNewsWire